Bioabsorbable Therapeutics, Inc.

Date	Article

09/08/2008	Positive Results for Bioabsorbable Therapeutics Salix™ Drug-Eluting Stent Coating
	Menlo Park - A study published in August 2008 Catheterization and Cardiovascular Interventions demonstrates the safety and efficacy of a novel and innately anti-inflammatory bioabsorbable polymer. Salix™, the polymer evaluated...

05/10/2007	Bioabsorbable Therapeutics, Inc. Raises Series B Investment Round for Novel Biodegradable Stent
	MENLO PARK, Calif. - Bioabsorbable Therapeutics Inc. announced the close of a Series B round of US$9MM today. CEO Patrick Rivelli said, "We are delighted with the investment round, led by Finistere Ventures LLC and ITX International Equity Corp. This investment will help us begin human clinical...

Company